tiprankstipranks
Advertisement
Advertisement

IceCure Medical Calls May 11 Special Meeting to Approve Potential Reverse Share Split

Story Highlights
  • IceCure Medical scheduled a May 11, 2026 remote special meeting to vote on a reverse share split.
  • Shareholders will decide on authorizing a 10:1 to 30:1 reverse split, key for Nasdaq compliance and requiring active voting participation.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
IceCure Medical Calls May 11 Special Meeting to Approve Potential Reverse Share Split

Claim 55% Off TipRanks

The latest announcement is out from Icecure Medical ( (ICCM) ).

IceCure Medical has called a special general meeting of shareholders to be held remotely on May 11, 2026, with a record date of April 27, 2026, to vote on a single proposal. The board is seeking shareholder approval for a potential reverse split of the company’s ordinary shares at a ratio between 10:1 and 30:1, to be implemented at the board’s discretion if approved.

The board of directors is unanimously recommending a vote in favor of the reverse split authority, which could support the company’s continued compliance with Nasdaq listing standards by boosting the per-share trading price. The notice details voting procedures for both registered and beneficial shareholders, emphasizing that brokers cannot vote uninstructed shares on this non-routine item, making active shareholder participation critical to the outcome.

The most recent analyst rating on (ICCM) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on Icecure Medical stock, see the ICCM Stock Forecast page.

Spark’s Take on ICCM Stock

According to Spark, TipRanks’ AI Analyst, ICCM is a Neutral.

The score is held down primarily by weak financial performance (large ongoing losses, heavy cash burn, and shrinking equity) and bearish technicals (price below major moving averages with negative MACD). A more positive earnings-call outlook around regulatory validation and expected commercialization acceleration provides some support, but valuation remains constrained by continued losses and no dividend.

To see Spark’s full report on ICCM stock, click here.

More about Icecure Medical

IceCure Medical Ltd. is an Israel-based medical device company focused on minimally invasive cryoablation technologies for the treatment of tumors. The company’s ordinary shares are listed on the Nasdaq Stock Market, and its shareholder base includes both registered holders and beneficial owners holding through banks and brokers.

Average Trading Volume: 447,205

Technical Sentiment Signal: Sell

Current Market Cap: $24.87M

For a thorough assessment of ICCM stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1